[en] 18-FDG is accumulated in cancer cells. It has been proven useful to image a variety of tumors in conjunction with whole-body positron emission tomography. This review details somes of the indications of PET at various stages of the cancerous process : differential diagnosis, preoperative staging, diagnosis of residual or recurrent disease as well as follow-up of therapy. Consideration of several potential improvements in clinical PET and of the need for careful patients selection conclude this review.
Disciplines :
Radiology, nuclear medicine & imaging Oncology
Author, co-author :
Rigo, Pierre ; Université de Liège - ULiège > Département des sciences de la motricité > Pathologie générale et médecine nucléaire
Paulus, Patrick
Bury, Thierry ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Jerusalem, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Hustinx, Roland ; Université de Liège - ULiège > Département des sciences cliniques > Médecine nucléaire
Benoit, Thérèse
Larock, Marie-Paule ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire
Willems, Jacqueline ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire
Language :
English
Title :
Clinical PET in Oncology
Publication date :
1997
Main work title :
Radioactive Isotopes in Clinical Medicine and Research
